Non-oral therapies burden PAH patients

Robyn Kalda
Aug 4
1 min read

This study looked at the challenges and impacts of non-oral treatments for pulmonary arterial hypertension (PAH), beyond those caused by PAH itself. They found that people taking oral-only therapies and people taking non-oral therapy had similar health, but those taking non-oral therapy had worse quality of life, as non-oral therapy interfered with daily activities.

Read the Therapeutic Advances in Respiratory Disease article

Recent Posts

Air pollution may worsen PAH

Air pollution is known to be bad for heart and lung diseases, but this study looked at whether it affected pulmonary arterial hypertension (PAH) in particular. They followed a cohort of patients for a

Kettlebell exercise training was safe and effective for PAH patients

A small study of patients with stable pulmonary arterial hypertension (PAH) were randomly assigned to either no exercise program or an exercise program using kettlebells three days per week for 8 week

Prostacyclin analogues protect against age-related macular degeneration

A study found that people taking infused prostacyclin analogues for pulmonary hypertension had a significantly lower risk of developing age-related macular degeneration, an eye problem that causes vis

Comments